Efficacy of low-dose boosted saquinavir once daily plus nucleoside reverse transcriptase inhibitors in pregnant HIV-1-infected women with a therapeutic drug monitoring strategy. [electronic resource]
- Therapeutic drug monitoring Apr 2007
- 171-6 p. digital
Publication Type: Journal Article; Multicenter Study
0163-4356
10.1097/FTD.0b013e31803bb54e doi
Adult Drug Monitoring Drug Therapy, Combination Female HIV Infections--drug therapy HIV Protease Inhibitors--adverse effects Humans Infectious Disease Transmission, Vertical--prevention & control Pregnancy Pregnancy Complications, Infectious--drug therapy Prospective Studies Reverse Transcriptase Inhibitors--therapeutic use Ritonavir--therapeutic use Saquinavir--adverse effects Viral Load